KR101807885B1 - 개선된 백색도 특징을 가지는 산화은 제제 - Google Patents

개선된 백색도 특징을 가지는 산화은 제제 Download PDF

Info

Publication number
KR101807885B1
KR101807885B1 KR1020127004440A KR20127004440A KR101807885B1 KR 101807885 B1 KR101807885 B1 KR 101807885B1 KR 1020127004440 A KR1020127004440 A KR 1020127004440A KR 20127004440 A KR20127004440 A KR 20127004440A KR 101807885 B1 KR101807885 B1 KR 101807885B1
Authority
KR
South Korea
Prior art keywords
zinc oxide
oxide
silver
silver oxide
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020127004440A
Other languages
English (en)
Korean (ko)
Other versions
KR20120037017A (ko
Inventor
페리 안텔만
Original Assignee
에이던스 스킨케어 앤드 토피컬 솔루션즈 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이던스 스킨케어 앤드 토피컬 솔루션즈 엘엘씨 filed Critical 에이던스 스킨케어 앤드 토피컬 솔루션즈 엘엘씨
Publication of KR20120037017A publication Critical patent/KR20120037017A/ko
Application granted granted Critical
Publication of KR101807885B1 publication Critical patent/KR101807885B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020127004440A 2009-07-21 2010-07-21 개선된 백색도 특징을 가지는 산화은 제제 Expired - Fee Related KR101807885B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22729709P 2009-07-21 2009-07-21
US61/227,297 2009-07-21
GB1003870.1 2010-03-09
GB1003870A GB2472126B (en) 2009-07-21 2010-03-09 Topical Formulations Containing Silver (II) Oxide and Zinc Oxide
PCT/IB2010/002024 WO2011010221A1 (en) 2009-07-21 2010-07-21 Silver oxide formulations having improved whiteness characteristics

Publications (2)

Publication Number Publication Date
KR20120037017A KR20120037017A (ko) 2012-04-18
KR101807885B1 true KR101807885B1 (ko) 2017-12-11

Family

ID=42136680

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127004440A Expired - Fee Related KR101807885B1 (ko) 2009-07-21 2010-07-21 개선된 백색도 특징을 가지는 산화은 제제

Country Status (11)

Country Link
US (1) US8647647B2 (https=)
EP (1) EP2456447B1 (https=)
JP (1) JP5883785B2 (https=)
KR (1) KR101807885B1 (https=)
CN (1) CN102470148B (https=)
AU (1) AU2010274654B2 (https=)
CA (1) CA2806198C (https=)
GB (1) GB2472126B (https=)
IL (1) IL217660A (https=)
WO (1) WO2011010221A1 (https=)
ZA (1) ZA201200963B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391124B2 (en) 2009-07-21 2019-08-27 Aidance Skincare & Topical Solutions Llc Silver oxide formulations
GB2487438B8 (en) * 2011-01-24 2014-08-06 Aidance Skincare & Topical Solutions Llc Stable silver oxide formulations
US9687509B2 (en) * 2009-11-06 2017-06-27 Aidance Skincare And Topical Solutions, Llc Silver oxide formulations
US20130189372A1 (en) * 2010-02-06 2013-07-25 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
CN106211756B (zh) * 2014-01-27 2019-12-27 帮助护肤及局部解决方案公司 局部用抗生素制剂
TW201630994A (zh) * 2015-02-08 2016-09-01 阿爾賈曼技術有限公司 使用於安全面罩及個人防護衣物的抗微生物織物材料
CN107207771B (zh) 2015-02-08 2019-12-06 阿尔贾曼技术有限公司 包含金属氧化物的协同组合的抗微生物材料
US11224227B2 (en) 2015-02-08 2022-01-18 Argaman Technologies Ltd. Antimicrobial material comprising synergistic combinations of metal oxides
TWI754608B (zh) * 2015-02-08 2022-02-11 以色列商阿爾賈曼技術有限公司 包含金屬氧化物之協同組合的皮膚再生材料
CZ2018477A3 (cs) * 2018-09-17 2020-04-29 Ĺ KODA AUTO a.s. Soustava pro upevnění prosvětlené masky chladiče
DE102024111212A1 (de) * 2024-04-22 2025-10-23 Boehm Medical Protection GmbH Dermale pharmazeutische Zusammensetzung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519188A (ja) * 2000-01-06 2003-06-17 マランテック ホールディング リミテッド ライアビリティ カンパニー 皮膚増殖の促進及び皮膚症状の処置のための組成物及び方法
US20060171971A1 (en) * 2005-02-01 2006-08-03 The Procter & Gamble Company Composition for wet wipes containing a non-irritating skin health benefit ingredient and the process for making
JP2010516719A (ja) 2007-01-23 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗菌性組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2521713A (en) * 1945-07-23 1950-09-12 Sunshine Mining Company Method for producing a microbicidal composition of matter
US4489223A (en) * 1982-07-28 1984-12-18 Smart Start Corporation Battery jump cable apparatus
ATE88324T1 (de) * 1984-12-28 1993-05-15 Johnson Matthey Plc Antimikrobielle zusammensetzungen.
JPH02268104A (ja) * 1989-04-07 1990-11-01 Kanebo Ltd 抗菌性組成物
EP0427858A4 (en) * 1989-02-28 1993-03-10 Kanebo Ltd. Antibacterial or conductive composition and applications thereof
JPH02265605A (ja) * 1989-04-06 1990-10-30 Tetsuo Nishida 固液分離装置
US5336499A (en) 1992-01-10 1994-08-09 Antelman Technologies, Ltd. Molecular crystal device for pharmaceuticals
US6258385B1 (en) 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
US6485755B1 (en) 2000-01-06 2002-11-26 Marantech Holding Methods of using electron active compounds for managing cancer
US6669966B1 (en) 2000-01-06 2003-12-30 Marantech Holding Llc Compositions for facilitating skin growth and methods and articles using same
US6645531B1 (en) 2000-01-06 2003-11-11 Marantech Holding Llc Multivalent electron active compositions and methods of making and using same
US20060105057A1 (en) * 2000-01-06 2006-05-18 Marantech Holding, Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US20040247696A1 (en) 2001-07-05 2004-12-09 Antelman Marvin S. Methods of using electron active compounds for managing conditions afflicting mammals
KR20060015514A (ko) * 2003-04-18 2006-02-17 메르크 파텐트 게엠베하 항미생물 안료
US20060017197A1 (en) * 2004-07-20 2006-01-26 Christensen Donald J Coring of compression-molded phenolic
CN100394986C (zh) * 2004-11-09 2008-06-18 深圳市源兴生物医药科技有限公司 一种含银锌组合物的创伤敷料
CN1778313A (zh) * 2004-11-22 2006-05-31 深圳市清华源兴生物医药科技有限公司 一种防治皮肤浅部真菌感染和妇女生殖道感染的药物
WO2007000591A2 (en) 2005-06-27 2007-01-04 Smith & Nephew, Plc Antimicrobial materials
US20080014278A1 (en) * 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
US8894980B2 (en) * 2007-11-19 2014-11-25 U.S. Cosmetics Corporation Wet cake composition for cosmetic products and methods of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519188A (ja) * 2000-01-06 2003-06-17 マランテック ホールディング リミテッド ライアビリティ カンパニー 皮膚増殖の促進及び皮膚症状の処置のための組成物及び方法
US20060171971A1 (en) * 2005-02-01 2006-08-03 The Procter & Gamble Company Composition for wet wipes containing a non-irritating skin health benefit ingredient and the process for making
JP2010516719A (ja) 2007-01-23 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗菌性組成物

Also Published As

Publication number Publication date
GB201003870D0 (en) 2010-04-21
US8647647B2 (en) 2014-02-11
AU2010274654A1 (en) 2012-02-23
JP2012533614A (ja) 2012-12-27
EP2456447A1 (en) 2012-05-30
ZA201200963B (en) 2013-05-29
CA2806198A1 (en) 2011-01-27
JP5883785B2 (ja) 2016-03-15
CA2806198C (en) 2018-02-13
WO2011010221A1 (en) 2011-01-27
CN102470148A (zh) 2012-05-23
AU2010274654B2 (en) 2016-04-28
CN102470148B (zh) 2015-04-01
GB2472126A (en) 2011-01-26
IL217660A (en) 2016-02-29
EP2456447A4 (en) 2013-01-02
US20110020468A1 (en) 2011-01-27
KR20120037017A (ko) 2012-04-18
EP2456447B1 (en) 2016-08-24
GB2472126B (en) 2011-08-03

Similar Documents

Publication Publication Date Title
KR101807885B1 (ko) 개선된 백색도 특징을 가지는 산화은 제제
US10350219B2 (en) Antimicrobial compositions and methods of making the same
JP2017536402A (ja) バイオガラスを含む抗菌性組成物
JP6987039B2 (ja) 抗菌剤と組み合わせた中極性油の細菌性バイオフィルムに対する相乗的抗菌活性
CN107185031A (zh) 一种具有生物活性的医用敷料及其制备方法
HK1224175A1 (zh) 用於减少痂形成并促进癒合的组合物
CN104207957B (zh) 一种具有缩阴美白作用的蚕丝蛋白护理液及其制备方法
CN110420257A (zh) 一种复合奶牛乳头药浴液及其制备方法
CN105999360B (zh) 一种抗菌液体创可贴及其制备方法
KR20230135304A (ko) 1,2-데칸다이올을 유효 성분으로 포함하는 보존제 조성물 및 이의 제조 방법
US9629913B2 (en) Silver oxide formulations
CN1117710A (zh) 化妆品组合物
CN108992462A (zh) 一种复方聚维酮碘组合物及其制备方法
JP2022522992A (ja) 爪甲真菌症のためのワセリンベースｐｈｍｂ組成物及び治療方法
US20260048173A1 (en) ECO-SKIN: A Kombucha SCOBY-Derived Cellulose Matrix for Accelerated Healing and Antimicrobial Defense
US12485142B2 (en) Silver oxide formulations
CN107625703A (zh) 可形成荷正电抗菌修护膜的护臀霜及其制备方法
CN102223859B (zh) 脂肪酸酯设置在棉塞上和毒素抑制效力
CN119656077A (zh) 调节皮脂腺的组合物及其制备方法和应用
CN111450001A (zh) 一种具有抑菌效果的护手霜及其制备方法
WO2012103011A1 (en) Stable silver oxide formulations

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241206

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241206

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241206